tradingkey.logo
tradingkey.logo
Search

Novocure To Present Final Results From Pivotal Phase 3 Metis Trial Of Its Tumor Treating Fields Therapy For Brain Metastases From Non-Small Cell Lung Cancer At 2025 Astro Annual Meeting

ReutersSep 29, 2025 9:02 PM
facebooktwitterlinkedin
View all comments0

- Novocure Ltd NVCR.O:

  • NOVOCURE TO PRESENT FINAL RESULTS FROM THE PIVOTAL PHASE 3 METIS TRIAL OF ITS TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER AT 2025 ASTRO ANNUAL MEETING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI